<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10203125</article-id><article-id pub-id-type="pmcid-ver">PMC10203125.1</article-id><article-id pub-id-type="pmcaid">10203125</article-id><article-id pub-id-type="pmcaiid">10203125</article-id><article-id pub-id-type="pmid">37217800</article-id><article-id pub-id-type="doi">10.1038/s41598-023-35493-x</article-id><article-id pub-id-type="publisher-id">35493</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hosseini-Esfahani</surname><given-names initials="F">Firoozeh</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Beheshti</surname><given-names initials="N">Niloofar</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nematollahi</surname><given-names initials="A">Amene</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Koochakpoor</surname><given-names initials="G">Glareh</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>verij-Kazemi</surname><given-names initials="S">Soheil</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Mirmiran</surname><given-names initials="P">Parvin</given-names></name><address><email>mirmiran@endocrine.ac.ir</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Azizi</surname><given-names initials="F">Fereidoon</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411600.2</institution-id><institution>Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, </institution><institution>Shahid Beheshti University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05bh0zx16</institution-id><institution-id institution-id-type="GRID">grid.411135.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0415 3047</institution-id><institution>Department of Food Safety and Hygiene, School of Health, </institution><institution>Fasa University of Medical Sciences, </institution></institution-wrap>Fasa, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0037djy87</institution-id><institution-id institution-id-type="GRID">grid.449862.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0518 4224</institution-id><institution>Maragheh University of Medical Sciences, </institution></institution-wrap>Maragheh, Iran </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.411600.2</institution-id><institution>Endocrine Research Center, Research Institute for Endocrine Sciences, </institution><institution>Shahid Beheshti University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>5</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>13</volume><issue-id pub-id-type="pmc-issue-id">425018</issue-id><elocation-id>8235</elocation-id><history><date date-type="received"><day>5</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>18</day><month>5</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>05</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>24</day><month>05</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-02-11 22:25:10.350"><day>11</day><month>02</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2023_Article_35493.pdf"/><abstract id="Abs1"><p id="Par1">This study aimed at investigating the association of acrylamide consumption with the incidence of type 2 diabetes (T2D) in adults. The 6022 subjects of the Tehran lipid and glucose study participants were selected. The acrylamide content of food items were summed and computed cumulatively across follow up surveys. Multivariable Cox proportional hazard regression analyses were performed to estimate the hazards ratio (HR) and 95% confidence interval (CI) of incident T2D. This study was done on men and women, respectively aged 41.5&#8201;&#177;&#8201;14.1 and 39.2&#8201;&#177;&#8201;13.0&#160;years. The mean&#8201;&#177;&#8201;SD of dietary acrylamide intake was 57.0&#8201;&#177;&#8201;46.8&#160;&#181;g/day. Acrylamide intake was not associated with the incidence of T2D after adjusting for confounding variables. In women, a higher acrylamide intake was positively associated with T2D [HR (CI) for Q4: 1.13 (1.01&#8211;1.27), P trend: 0.03] after adjusting for confounding factors. Our results demonstrated that dietary intake of acrylamide was associated with an increased risk of T2D in women.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Diseases</kwd><kwd>Endocrinology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007427</institution-id><institution>Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences</institution></institution-wrap></funding-source><award-id>29965</award-id><principal-award-recipient><name name-style="western"><surname>Mirmiran</surname><given-names>Parvin</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Acrylamide is produced during the preparation of high-carbohydrate foods such as potato chips, french-fries and breads which contain the amino acid asparagine<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. When these foods are prepared at high temperatures (120&#160;&#176;C), sugar reacts with asparagine through Millard Reaction and acrylamide produced up to 1&#160;mg/kg food<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Furthermore, acrylamide is also part of tobacco smoke<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Two main sources of public exposure to acrylamide are food and cigarette smoke.</p><p id="Par3">Dietary acrylamide could be an important human health risk factor; previous studies observed neurotoxicity in workers exposed to acrylamide in the workplace<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. Moreover, animal studies reported the relationship of acrylamide intake with significant carcinogenic and neurotoxic risk<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. Epidemiological studies have issued conclusive evidence that dietary acrylamide exposure is associated with the risk of cancers in humans<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>; there are also studies that reported a significant association between dietary acrylamide intake and risk of renal, endometrial, and ovarian cancers<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. International Agency for Research on Cancer considers acrylamide as a probable human carcinogen<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. The effect of acrylamide in increasing oxidative DNA damage in target organs is one of the suggested mechanisms that explain the carcinogenicity of acrylamide<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Recent studies indicated that long-term high levels of dietary acrylamide intake may induce oxidative stress and chronic inflammation<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Prevalence of type 2 diabetes (T2D), a metabolic disorders characterized by increased blood glucose concentration, increase across the worldwide<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. The etiology of diabetes remains mainly unspecified<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>; however, the common pathogenic mediators in the natural course of diabetes is oxidative stress<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. These findings suggest this thesis that acrylamide intake may be actual in the onset of T2D. In the study by Wang et al., ingested acrylamide was associated with fasting plasma glucose elevation, oxidative DNA damage and lipid peroxidation in 3270 adults; the significant linear positive dose&#8211;response relationship was found between urinary acrylamide metabolite and fasting plasma glucose<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. In the study by Lin et al., a 1 unit rise in Hb adducts of acrylamide was related to both reduced blood insulin and reduced insulin resistance; this association was stronger in subjects with a lower education level, smokers, whites and in subjects with body mass index (BMI) &lt;&#8201;25 or &gt;&#8201;30&#160;kg/m<sup>2</sup> than their counterparts<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. The existence of such contradictory results led us to perform a cohort study aimed at investigating the association of acrylamide consumption with the incidence of T2D in a group of Iranian adults.</p></sec><sec id="Sec2"><title>Results</title><p id="Par4">This study was done on 2707 men and 3315 women (n&#8201;=&#8201;6022), respectively aged 41.5&#8201;&#177;&#8201;14.1 and 39.2&#8201;&#177;&#8201;13.0&#160;years. The participants include 5563 censors and 549 incident cases of T2D during a median of 6.63&#160;years of follow up. The mean&#8201;&#177;&#8201;SD of dietary acrylamide intake was 57.0&#8201;&#177;&#8201;46.8&#160;&#181;g/day (median: 46.4&#160;&#181;g/day).</p><p id="Par5">The baseline characteristics of the subjects across quartiles of acrylamide intake are shown in Table <xref rid="Tab1" ref-type="table">1</xref>. We found that those who consumed higher acrylamide intakes were younger (Q1: 43.2&#8201;&#177;&#8201;14.3, Q4: 37.9&#8201;&#177;&#8201;12.7, P&#8201;&lt;&#8201;0.001). The percentage of active smokers was higher in the upper quartiles of acrylamide intake (Q1-Q4: 13.0, 16.7, 22.2, 28.0%). The level of physical activity was higher in the upper quartiles of acrylamide intake (Q1: 495&#8201;&#177;&#8201;684, Q4: 640&#8201;&#177;&#8201;995, P&#8201;&lt;&#8201;0.001).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics of adult participants of the Tehran Lipid and Glucose Study across quartiles of acrylamide intake (n&#8201;=&#8201;6022).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="4" rowspan="1">Acrylamide intake</th><th align="left" rowspan="2" colspan="1">P</th></tr><tr><th align="left" colspan="1" rowspan="1">Q1</th><th align="left" colspan="1" rowspan="1">Q2</th><th align="left" colspan="1" rowspan="1">Q3</th><th align="left" colspan="1" rowspan="1">Q4</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">n</td><td align="left" colspan="1" rowspan="1">1504</td><td align="left" colspan="1" rowspan="1">1506</td><td align="left" colspan="1" rowspan="1">1506</td><td align="left" colspan="1" rowspan="1">1506</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Acrylamide (&#181;g/day)</td><td align="left" colspan="1" rowspan="1">23.3&#8201;&#177;&#8201;5.98</td><td align="left" colspan="1" rowspan="1">38.9&#8201;&#177;&#8201;4.30</td><td align="left" colspan="1" rowspan="1">55.8&#8201;&#177;&#8201;6.03</td><td align="left" colspan="1" rowspan="1">106&#8201;&#177;&#8201;68.3</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Baseline age (years)</td><td align="left" colspan="1" rowspan="1">43.2&#8201;&#177;&#8201;14.3</td><td align="left" colspan="1" rowspan="1">40.8&#8201;&#177;&#8201;13.5</td><td align="left" colspan="1" rowspan="1">39.0&#8201;&#177;&#8201;13.1</td><td align="left" colspan="1" rowspan="1">37.9&#8201;&#177;&#8201;12.7</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (%)</td><td align="left" colspan="1" rowspan="1">73.3</td><td align="left" colspan="1" rowspan="1">59.8</td><td align="left" colspan="1" rowspan="1">41.7</td><td align="left" colspan="1" rowspan="1">40</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Smoking (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Non-smokers</td><td align="left" colspan="1" rowspan="1">69.6</td><td align="left" colspan="1" rowspan="1">66.5</td><td align="left" colspan="1" rowspan="1">58.7</td><td align="left" colspan="1" rowspan="1">51.8</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Passive smoker</td><td align="left" colspan="1" rowspan="1">17.4</td><td align="left" colspan="1" rowspan="1">16.3</td><td align="left" colspan="1" rowspan="1">19.1</td><td align="left" colspan="1" rowspan="1">20.1</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Active smoker</td><td align="left" colspan="1" rowspan="1">13.0</td><td align="left" colspan="1" rowspan="1">16.7</td><td align="left" colspan="1" rowspan="1">22.2</td><td align="left" colspan="1" rowspan="1">28.0</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Family history of diabetes (%)</td><td align="left" colspan="1" rowspan="1">14.4</td><td align="left" colspan="1" rowspan="1">12.3</td><td align="left" colspan="1" rowspan="1">14.4</td><td align="left" colspan="1" rowspan="1">14.3</td><td char="." align="char" colspan="1" rowspan="1">0.60</td></tr><tr><td align="left" colspan="1" rowspan="1">Physical activity (MET/min/week)</td><td align="left" colspan="1" rowspan="1">495&#8201;&#177;&#8201;684</td><td align="left" colspan="1" rowspan="1">500&#8201;&#177;&#8201;733</td><td align="left" colspan="1" rowspan="1">587&#8201;&#177;&#8201;871</td><td align="left" colspan="1" rowspan="1">640&#8201;&#177;&#8201;995</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Education (&#8805;&#8201;12&#160;years)</td><td align="left" colspan="1" rowspan="1">20.2</td><td align="left" colspan="1" rowspan="1">25.5</td><td align="left" colspan="1" rowspan="1">29.9</td><td align="left" colspan="1" rowspan="1">32.2</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">27.3&#8201;&#177;&#8201;4.92</td><td align="left" colspan="1" rowspan="1">27.0&#8201;&#177;&#8201;4.74</td><td align="left" colspan="1" rowspan="1">26.7&#8201;&#177;&#8201;4.70</td><td align="left" colspan="1" rowspan="1">26.9&#8201;&#177;&#8201;4.68</td><td char="." align="char" colspan="1" rowspan="1">0.17</td></tr><tr><td align="left" colspan="1" rowspan="1">Waist circumference (cm)</td><td align="left" colspan="1" rowspan="1">88.2&#8201;&#177;&#8201;13.5</td><td align="left" colspan="1" rowspan="1">88.5&#8201;&#177;&#8201;13.0</td><td align="left" colspan="1" rowspan="1">88.8&#8201;&#177;&#8201;13.2</td><td align="left" colspan="1" rowspan="1">90.3&#8201;&#177;&#8201;12.8</td><td char="." align="char" colspan="1" rowspan="1">0.007</td></tr><tr><td align="left" colspan="1" rowspan="1">Fasting blood glucose (mg/dl)</td><td align="left" colspan="1" rowspan="1">90.2&#8201;&#177;&#8201;9.39</td><td align="left" colspan="1" rowspan="1">90.4&#8201;&#177;&#8201;8.95</td><td align="left" colspan="1" rowspan="1">90.1&#8201;&#177;&#8201;8.91</td><td align="left" colspan="1" rowspan="1">90.7&#8201;&#177;&#8201;8.95</td><td char="." align="char" colspan="1" rowspan="1">0.29</td></tr><tr><td align="left" colspan="1" rowspan="1">Systolic BP (mmHg)</td><td align="left" colspan="1" rowspan="1">111&#8201;&#177;&#8201;16.9</td><td align="left" colspan="1" rowspan="1">111&#8201;&#177;&#8201;16.7</td><td align="left" colspan="1" rowspan="1">112&#8201;&#177;&#8201;15.7</td><td align="left" colspan="1" rowspan="1">111&#8201;&#177;&#8201;14.8</td><td char="." align="char" colspan="1" rowspan="1">0.23</td></tr><tr><td align="left" colspan="1" rowspan="1">Diastolic BP (mmHg)</td><td align="left" colspan="1" rowspan="1">73.9&#8201;&#177;&#8201;10.6</td><td align="left" colspan="1" rowspan="1">74.4&#8201;&#177;&#8201;10.9</td><td align="left" colspan="1" rowspan="1">74.63&#8201;&#177;&#8201;10.7</td><td align="left" colspan="1" rowspan="1">75.02&#8201;&#177;&#8201;10.5</td><td char="." align="char" colspan="1" rowspan="1">0.10</td></tr><tr><td align="left" colspan="1" rowspan="1">Triglyceride (mg/dl)</td><td align="left" colspan="1" rowspan="1">134&#8201;&#177;&#8201;76.9</td><td align="left" colspan="1" rowspan="1">138&#8201;&#177;&#8201;79.1</td><td align="left" colspan="1" rowspan="1">138&#8201;&#177;&#8201;82.7</td><td align="left" colspan="1" rowspan="1">140&#8201;&#177;&#8201;88.0</td><td char="." align="char" colspan="1" rowspan="1">0.27</td></tr><tr><td align="left" colspan="1" rowspan="1">HDL (mg/dl)</td><td align="left" colspan="1" rowspan="1">47.3&#8201;&#177;&#8201;11.4</td><td align="left" colspan="1" rowspan="1">45.7&#8201;&#177;&#8201;11.0</td><td align="left" colspan="1" rowspan="1">44.7&#8201;&#177;&#8201;10.7</td><td align="left" colspan="1" rowspan="1">44.7&#8201;&#177;&#8201;10.4</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Energy intake (kcal/day)</td><td align="left" colspan="1" rowspan="1">1879&#8201;&#177;&#8201;481</td><td align="left" colspan="1" rowspan="1">2152&#8201;&#177;&#8201;465</td><td align="left" colspan="1" rowspan="1">2432&#8201;&#177;&#8201;495</td><td align="left" colspan="1" rowspan="1">2704&#8201;&#177;&#8201;610</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Carbohydrate (% of energy)</td><td align="left" colspan="1" rowspan="1">58.4&#8201;&#177;&#8201;6.00</td><td align="left" colspan="1" rowspan="1">59.0&#8201;&#177;&#8201;5.37</td><td align="left" colspan="1" rowspan="1">59.1&#8201;&#177;&#8201;5.31</td><td align="left" colspan="1" rowspan="1">59.6&#8201;&#177;&#8201;5.66</td><td char="." align="char" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Protein (% of energy)</td><td align="left" colspan="1" rowspan="1">14.6&#8201;&#177;&#8201;2.75</td><td align="left" colspan="1" rowspan="1">14.7&#8201;&#177;&#8201;2.49</td><td align="left" colspan="1" rowspan="1">14.7&#8201;&#177;&#8201;2.20</td><td align="left" colspan="1" rowspan="1">14.9&#8201;&#177;&#8201;3.24</td><td char="." align="char" colspan="1" rowspan="1">0.37</td></tr><tr><td align="left" colspan="1" rowspan="1">Total fat (% of energy)</td><td align="left" colspan="1" rowspan="1">30.3&#8201;&#177;&#8201;5.66</td><td align="left" colspan="1" rowspan="1">29.7&#8201;&#177;&#8201;5.12</td><td align="left" colspan="1" rowspan="1">29.6&#8201;&#177;&#8201;5.09</td><td align="left" colspan="1" rowspan="1">29.3&#8201;&#177;&#8201;6.73</td><td char="." align="char" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">SFA (% of energy)</td><td align="left" colspan="1" rowspan="1">9.97&#8201;&#177;&#8201;2.45</td><td align="left" colspan="1" rowspan="1">9.62&#8201;&#177;&#8201;2.13</td><td align="left" colspan="1" rowspan="1">9.61&#8201;&#177;&#8201;3.40</td><td align="left" colspan="1" rowspan="1">9.45&#8201;&#177;&#8201;5.40</td><td char="." align="char" colspan="1" rowspan="1">0.008</td></tr><tr><td align="left" colspan="1" rowspan="1">MUFA (% of energy)</td><td align="left" colspan="1" rowspan="1">10.2&#8201;&#177;&#8201;2.52</td><td align="left" colspan="1" rowspan="1">9.96&#8201;&#177;&#8201;2.05</td><td align="left" colspan="1" rowspan="1">9.96&#8201;&#177;&#8201;2.18</td><td align="left" colspan="1" rowspan="1">9.96&#8201;&#177;&#8201;5.25</td><td char="." align="char" colspan="1" rowspan="1">0.14</td></tr><tr><td align="left" colspan="1" rowspan="1">PUFA (% of energy)</td><td align="left" colspan="1" rowspan="1">6.15&#8201;&#177;&#8201;1.89</td><td align="left" colspan="1" rowspan="1">6.02&#8201;&#177;&#8201;1.59</td><td align="left" colspan="1" rowspan="1">6.00&#8201;&#177;&#8201;1.54</td><td align="left" colspan="1" rowspan="1">6.05&#8201;&#177;&#8201;5.11</td><td char="." align="char" colspan="1" rowspan="1">0.89</td></tr><tr><td align="left" colspan="1" rowspan="1">Fiber (g/1000&#160;kcal)</td><td align="left" colspan="1" rowspan="1">10.9&#8201;&#177;&#8201;11.1</td><td align="left" colspan="1" rowspan="1">10.2&#8201;&#177;&#8201;4.01</td><td align="left" colspan="1" rowspan="1">9.75&#8201;&#177;&#8201;2.56</td><td align="left" colspan="1" rowspan="1">9.63&#8201;&#177;&#8201;2.78</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Breads (g/day)</td><td align="left" colspan="1" rowspan="1">94.0&#8201;&#177;&#8201;42.0</td><td align="left" colspan="1" rowspan="1">142&#8201;&#177;&#8201;51.0</td><td align="left" colspan="1" rowspan="1">189&#8201;&#177;&#8201;73.0</td><td align="left" colspan="1" rowspan="1">256&#8201;&#177;&#8201;225</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Confectionary products (g/day)</td><td align="left" colspan="1" rowspan="1">4.28&#8201;&#177;&#8201;3.82</td><td align="left" colspan="1" rowspan="1">6.28&#8201;&#177;&#8201;5.24</td><td align="left" colspan="1" rowspan="1">7.66&#8201;&#177;&#8201;7.73</td><td align="left" colspan="1" rowspan="1">9.19&#8201;&#177;&#8201;11.2</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Roasted nuts (g/day)</td><td align="left" colspan="1" rowspan="1">4.03&#8201;&#177;&#8201;6.13</td><td align="left" colspan="1" rowspan="1">5.43&#8201;&#177;&#8201;8.12</td><td align="left" colspan="1" rowspan="1">6.92&#8201;&#177;&#8201;8.53</td><td align="left" colspan="1" rowspan="1">8.46&#8201;&#177;&#8201;13.4</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Snacks (g/day)</td><td align="left" colspan="1" rowspan="1">5.25&#8201;&#177;&#8201;5.38</td><td align="left" colspan="1" rowspan="1">8.16&#8201;&#177;&#8201;7.66</td><td align="left" colspan="1" rowspan="1">11.6&#8201;&#177;&#8201;11.3</td><td align="left" colspan="1" rowspan="1">15.9&#8201;&#177;&#8201;28.1</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Coffee (g/day)</td><td align="left" colspan="1" rowspan="1">1.56&#8201;&#177;&#8201;2.68</td><td align="left" colspan="1" rowspan="1">3.87&#8201;&#177;&#8201;5.43</td><td align="left" colspan="1" rowspan="1">7.87&#8201;&#177;&#8201;10.2</td><td align="left" colspan="1" rowspan="1">39.7&#8201;&#177;&#8201;65.7</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Fast food (g/day)</td><td align="left" colspan="1" rowspan="1">9.01&#8201;&#177;&#8201;9.85</td><td align="left" colspan="1" rowspan="1">13.0&#8201;&#177;&#8201;12.6</td><td align="left" colspan="1" rowspan="1">15.7&#8201;&#177;&#8201;16.7</td><td align="left" colspan="1" rowspan="1">20.9&#8201;&#177;&#8201;28.9</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Bakery products (g/day)</td><td align="left" colspan="1" rowspan="1">8.36&#8201;&#177;&#8201;8.99</td><td align="left" colspan="1" rowspan="1">13.0&#8201;&#177;&#8201;13.4</td><td align="left" colspan="1" rowspan="1">16.2&#8201;&#177;&#8201;17.1</td><td align="left" colspan="1" rowspan="1">19.3&#8201;&#177;&#8201;21.3</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p>Values are mean&#8201;&#177;&#8201;SD unless otherwise listed. <italic toggle="yes">Q</italic> quartiles of choline intake, <italic toggle="yes">BMI</italic> body mass index, <italic toggle="yes">BP</italic> blood pressure, <italic toggle="yes">HDL</italic> high density lipoprotein cholesterol, <italic toggle="yes">MUFA</italic> mono-unsaturated fatty acids, <italic toggle="yes">PUFA</italic> poly-unsaturated fatty acids, <italic toggle="yes">SFA</italic> saturated fat.</p></table-wrap-foot></table-wrap></p><p id="Par6">Moreover, individuals in the upper quartiles of acrylamide intake had higher intake of total energy (Q1: 1879&#8201;&#177;&#8201;481, Q4: 2704&#8201;&#177;&#8201;610&#160;kcal, P&#8201;&lt;&#8201;0.001), carbohydrate (Q1: 58.4&#8201;&#177;&#8201;6.00, Q4: 59.6&#8201;&#177;&#8201;5.66% of energy, P&#8201;=&#8201;0.001) and lower total fat (Q1: 30.3&#8201;&#177;&#8201;5.66, Q4: 29.3&#8201;&#177;&#8201;6.73% of energy, P&#8201;=&#8201;0.003) and saturated fatty acid intakes (Q1: 9.97&#8201;&#177;&#8201;2.45, Q4: 9.45&#8201;&#177;&#8201;5.40% of energy, P&#8201;=&#8201;0.008). The distribution of FBG, SBP, DBP and TG did not differ across quartiles of acrylamide intake; however, the level of WC (Q1: 88.2&#8201;&#177;&#8201;13.5, Q4: 90.3&#8201;&#177;&#8201;12.8&#160;cm, P&#8201;=&#8201;0.007) was higher in the upper quartiles of acrylamide intake and the level of HDL-C (Q1: 47.3&#8201;&#177;&#8201;11.4, Q4: 44.7&#8201;&#177;&#8201;10.4&#160;mg/dl, P&#8201;&lt;&#8201;0.001) was lower in higher quartiles of acrylamide intake.</p><p id="Par7">The main contributors of acrylamide intake were for bread food items and coffee. The contribution of acrylamide intake from bread food items decreased from lower to upper quartiles of acrylamide intake, but the contribution of coffee increased from lower to upper quartiles of acrylamide intake (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Contributors of dietary acrylamide intake from food items across quartiles of acrylamide intake.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="41598_2023_35493_Fig1_HTML.jpg"/></fig></p><p id="Par8">The Cox-proportional HRs for T2D based on quartiles of acrylamide intake is shown in Table <xref rid="Tab2" ref-type="table">2</xref>. Acrylamide intake was positively associated with the incidence of T2D in model 1 (P for trend&#8201;=&#8201;0.009); however, our results showed no association in model 2 after adjusting for confounding variables. Also the results of subgroup analysis were shown in this table. The association of acrylamide intake with T2D was not significant in subgroups of smoking categories. Our results indicated that after adjusting for confounding factors, a higher acrylamide intake was positively associated with T2D [HR (CI) for Q4: 1.13 (1.01&#8211;1.27), P for trend: 0.03] in women. In two subgroups of normal and overweight or obese individuals, there were no association between acrylamide intake and T2D.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Hazard ratios (95% CI) for the association of acrylamide intake and type 2 diabetes incidence in all participants and subgroups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="4" rowspan="1">Total acrylamide intake</th><th align="left" rowspan="2" colspan="1">P for trend</th></tr><tr><th align="left" colspan="1" rowspan="1">Q1</th><th align="left" colspan="1" rowspan="1">Q2</th><th align="left" colspan="1" rowspan="1">Q3</th><th align="left" colspan="1" rowspan="1">Q4</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Median intake (&#181;g/day)</td><td align="left" colspan="1" rowspan="1">24.2</td><td align="left" colspan="1" rowspan="1">38.9</td><td align="left" colspan="1" rowspan="1">55.5</td><td align="left" colspan="1" rowspan="1">87.7</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="6" rowspan="1">All participants (n&#8201;=&#8201;6022)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Model 1</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.01 (0.94&#8211;1.08)</td><td align="left" colspan="1" rowspan="1">1.04 (0.97&#8211;1.12)</td><td align="left" colspan="1" rowspan="1">1.10 (1.02&#8211;1.18)</td><td char="." align="char" colspan="1" rowspan="1">0.009</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Model 2</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.00 (0.93&#8211;1.08)</td><td align="left" colspan="1" rowspan="1">1.02 (0.94&#8211;1.11)</td><td align="left" colspan="1" rowspan="1">1.06 (0.98&#8211;1.16)</td><td char="." align="char" colspan="1" rowspan="1">0.13</td></tr><tr><td align="left" colspan="6" rowspan="1">Smoking*</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Non-exposed (n&#8201;=&#8201;3714)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.01 (0.92&#8211;1.11)</td><td align="left" colspan="1" rowspan="1">1.01 (0.92&#8211;1.11)</td><td align="left" colspan="1" rowspan="1">1.09 (0.98&#8211;1.22)</td><td char="." align="char" colspan="1" rowspan="1">0.24</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Passive smoker (n&#8201;=&#8201;1204)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">0.92 (0.77&#8211;1.10)</td><td align="left" colspan="1" rowspan="1">0.96 (0.80&#8211;1.16)</td><td align="left" colspan="1" rowspan="1">0.96 (0.79&#8211;1.16)</td><td char="." align="char" colspan="1" rowspan="1">0.70</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Active smoker (n&#8201;=&#8201;1104)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.08 (0.90&#8211;1.21)</td><td align="left" colspan="1" rowspan="1">1.15 (0.95&#8211;1.40)</td><td align="left" colspan="1" rowspan="1">1.14 (0.94&#8211;1.38)</td><td char="." align="char" colspan="1" rowspan="1">0.18</td></tr><tr><td align="left" colspan="6" rowspan="1">Sex<sup>&#8224;</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Men (n&#8201;=&#8201;2707)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">0.93 (0.83&#8211;1.07)</td><td align="left" colspan="1" rowspan="1">0.96 (0.84&#8211;1.08)</td><td align="left" colspan="1" rowspan="1">0.96 (0.84&#8211;1.11)</td><td char="." align="char" colspan="1" rowspan="1">0.85</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Women (n&#8201;=&#8201;3315)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.02 (0.93&#8211;1.12)</td><td align="left" colspan="1" rowspan="1">1.05 (0.95&#8211;1.16)</td><td align="left" colspan="1" rowspan="1">1.13 (1.01&#8211;1.27)</td><td char="." align="char" colspan="1" rowspan="1">0.03</td></tr><tr><td align="left" colspan="6" rowspan="1">BMI<sup>&#8224;&#8224;</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&lt;&#8201;25&#160;kg/m<sup>2</sup> (n&#8201;=&#8201;2134)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.05 (0.92&#8211;1.19)</td><td align="left" colspan="1" rowspan="1">1.04 (0.91&#8211;1.19)</td><td align="left" colspan="1" rowspan="1">1.07 (0.93&#8211;1.24)</td><td char="." align="char" colspan="1" rowspan="1">0.37</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;25&#160;kg/m<sup>2</sup> (n&#8201;=&#8201;3888)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">0.97 (0.88&#8211;1.06)</td><td align="left" colspan="1" rowspan="1">1.00 (0.91&#8211;1.07)</td><td align="left" colspan="1" rowspan="1">1.05 (0.94&#8211;1.16)</td><td char="." align="char" colspan="1" rowspan="1">0.27</td></tr></tbody></table><table-wrap-foot><p>Model 1: adjusted for age and sex, Model 2: Model 1 plus education, physical activity, family history of type 2 diabetes, body mass index, energy intake, triglyceride/high density lipoprotein cholesterol, smoking.</p><p>*Adjusted for age, sex, education, physical activity, history of type 2 diabetes, body mass index, energy intake, triglyceride/high density lipoprotein cholesterol.</p><p><sup><bold>&#8224;</bold></sup>Adjusted for age, education, physical activity, family history of type 2 diabetes, body mass index, energy intake, Triglyceride/High density lipoprotein cholesterol.</p><p><sup>&#8224;&#8224;</sup>Adjusted for age, education, physical activity, family history of type 2 diabetes, energy intake, triglyceride/high density lipoprotein cholesterol.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec3"><title>Discussion</title><p id="Par9">The present study examined the association of acrylamide intake with T2D incidence in a group of adults in the TLGS after 6.63&#160;years of follow up. Our findings showed that the contribution of acrylamide intake from bread food items was higher than other food groups including bakery products, coffee, roasted nuts, snacks, confectionary products and fast foods. Also acrylamide intake was positively associated with T2D incidence in total population; however, this association was not remained after adjusting for confounding variables. In this study we observed that a higher acrylamide intake was positively associated with the incidence of T2D in women, independent of other risk factors of T2D. There were no associations of acrylamide intake with T2D incidence in subgroups of smoking status, normal or overweight and obese individuals.</p><p id="Par10">There is a large variation in estimation of dietary acrylamide intake in different countries. The median of dietary acrylamide intake ranged from 5.9&#160;&#181;g/day in 45&#8211;74&#160;year old in Japan to 45&#160;&#181;g/day in a Swedish study among participants aged 45&#8211;73&#160;years. A review study reported that European countries had higher dietary acrylamide estimation than other countries in the world especially in Asia, which might be due to differences in study designs, methods and dietary habits; however, the estimation of dietary acrylamide intake in our study was slightly higher than the Swedish participants, a European country. It might be due to eating foods in a way that results in higher acrylamide formation<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>.</p><p id="Par11">In our study, the main food items responsible for acrylamide intake were respectively breads (52&#8211;62%), coffee (6&#8211;28%), snacks (7&#8211;10%), bakery products (5&#8211;7%), fast foods (4&#8211;6%) and roasted nuts (1&#8211;2%) in general population; while unlike our study, the expert committee on food additives reported that the principal food items accountable for acrylamide intake were respectively potato crisps (6&#8211;46%), potato chips (16&#8211;30%), coffee (13&#8211;39%), pastries and sweet biscuits (10&#8211;20%) and breads (10&#8211;30%)<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. In our study, most participants consumed a high carbohydrate diet (~&#8201;60% of energy intake) especially from refined sources (e.g. white bread)<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Also these results demonstrated that dietary acrylamide intake might be driven from staple foods such as breads that consumed in breakfast<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. So food industry operators can apply methods to reduce acrylamide formation in bakery products such as using natural antioxidants obtained from spices and herb extracts in bakery products<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p><p id="Par12">Furthermore, it was demonstrated that the more important source of acrylamide exposure is smoking compared to dietary intakes<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Moreover acrylamide toxicity has a cumulative nature, so the chronic exposure at low doses via different routes is important. Also acrylamide has been proven to disrupt the endocrine system<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>, so low dose chronic of acrylamide exposure may create important health problems and it may be a contributing factor to induce diabetes. Acrylamide exposure at both high and low doses can change oxidative stress parameters and inflammation that can lead to intensive lipid peroxidation and atherosclerosis<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p><p id="Par13">To our knowledge, this is the first population-based study to report an association of dietary acrylamide intake and T2D. Unlike to our findings in all participants, previous epidemiological studies reported the relation between acrylamide exposure and glucose metabolism. Wang et al. found that urinary acrylamide metabolites were positively associated with FBG in a dose response manner in a general urban adult population. Also they indicated that acrylamide exposure is positively associated with FBG, oxidative DNA damage and lipid peroxidation<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. In the American adult population, acrylamide exposure was associated with the insulin resistance and a decrease in insulin levels<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. In the national health and nutrition examination survey (NHANES) the association of T2D and acrylamide biomarkers including hemoglobin adducts of acrylamide and glycidamide (HbAA and HbGA) was reported. HbAA was linearly and inversely associated with the risk of T2D, while HbGA/HbAA was positively and non-linearly associated with T2D prevalence<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. HbAA and HbGA are considered as long-term exposure biomarkers of acrylamide in humans. Dietary acrylamide was positively correlated with HbAA and HbGA in previous studies; however, the results indicate that non-dietary exposure of acrylamide including tobacco smoke and environmental tobacco smoke (passive smoking) might increase the level of HbAA and HbGA which induce the significant result in this study<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. People who smoke tobacco products have 3&#8211;4 times higher exposure levels of acrylamide than non-smoker people<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>.</p><p id="Par14">There were increases in gluconeogenesis and glycogenolysis as well as reduction in glycolysis in the liver of rats. Change in gene expression may be responsible for these processes that may be associated with hypoinsulinemia and impaired insulin signaling pathway<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. In addition acrylamide can increase adipocyte differentiation through upregulation of the expression of adiposity-related genes. In vitro and in vivo studies found that acrylamide exposure in daily life can induce weight gain and promote obesity. These outcomes of acrylamide can influence different metabolic disease like diabetes<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p><p id="Par15">In our study we found that a higher acrylamide intake increased the risk of T2D incidence in women by 13%, independent of other risk factors of T2D; this association was not observed in men.</p><p id="Par16">The evidence on rats reported sex differences in FBG and insulin levels after AA exposure<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. They reported increase in FBG, decrease in insulin level and pancreatic islet injury under 30&#160;mg/kg body weight of AA exposure for three weeks in female rats, while similar results were observed after 50&#160;mg/kg body weight AA exposure in male rats. These differences may be due to higher AA absorption (3.53 fold) in female than in male rats<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>.</p><p id="Par17">Environmental chemicals could affect as antagonists or agonists through estrogenic or androgenic pathways. This pathway may disorder the number of hormone receptors and disrupt the levels of endogenous hormones. Dietary exposure of acrylamide was found to be associated with endocrine-related cancers in mammals. Also acrylamide intake might disorder thyroid homeostasis, altered sex hormone levels in cross-sectional studies<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>.</p><p id="Par18">Our study has several strengths. We used large scale prospective association of acrylamide intake with T2D. Also we used a full range of high quality measurement of outcome biomarkers. The measurement of acrylamide intake was performed in frequent surveys and cumulatively summed, so changes in the exposure was considered in determining long time risk of T2D. The use of acrylamide intake is less expensive than acrylamide biomarkers to be applied as an exposure in large population.</p><p id="Par19">However, some limitations should be regarded when interpreting these results. Although we had adjusted a range of potential confounders in our study, but some confounding factors including eating habits and food preparation methods were not estimated and they could not be adjusted in Cox regression models. Acrylamide exposure from cigarette smoking and occupation were not considered in this study since detailed occupational histories were not available in this study.</p></sec><sec id="Sec4"><title>Conclusion</title><p id="Par20">The results of our study demonstrated that dietary intake of acrylamide was associated with an increased risk of T2D in women of the TLGS cohort. People especially women should be aware of the findings of our study considering the adverse effect of acrylamide exposure with T2D in their lives.</p></sec><sec id="Sec5"><title>Materials and methods</title><sec id="Sec6"><title>Study population</title><p id="Par21">Participants were selected from the Tehran lipid and glucose study (TLGS), an extensive population-based cohort study performed to find out risk factors for non-communicable diseases in a representative sample of Tehran, the capital of Iran<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. The first survey was done from 1999 to 2001 on 15,005 individuals aged &#8805;&#8201;3&#160;years, using the composite stratified cluster random sampling technique. The follow-up surveys was done every 3&#160;years; 2002&#8211;2005 (survey 2), 2005&#8211;2008 (survey 3), 2008&#8211;2011 (survey 4), and 2012&#8211;2015 (survey 5) and 2015&#8211;2018 (survey 6). Of subjects participating in surveys 3 and 4, we randomly selected 8048 individuals (&#8805;&#8201;18&#160;years) with completed dietary assessment for this secondary analysis. We excluded subjects with under- or over-reporting of energy intake (&lt;&#8201;800 or &#8805;&#8201;4200&#160;kcal/day)<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> (n&#8201;=&#8201;780), then a total of 7268 adult men and women with available anthropometric, dietary, and biochemical data were followed until survey 6 (participants entering at surveys 3 and 4 were respectively followed three and two times). Of these individuals, we precluded pregnant or lactating women and subjects diagnosed with T2D at baseline based on measurement of fasting blood glucose (FBG) or self-reported taking glucose-lowering drugs<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> (n&#8201;=&#8201;598). Finally, after precluding individuals missing any follow-up data (n&#8201;=&#8201;498), 6022 participants remained and entered the analysis (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Outline of study participants&#8217; selection.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="41598_2023_35493_Fig2_HTML.jpg"/></fig></p><p id="Par22">All of the participants signed the written informed consent. The study was implemented in agreement with the Declaration of Helsinki rules and the study protocol was approved by the ethical committee of the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</p></sec><sec id="Sec7"><title>Dietary assessment</title><p id="Par23">Skilled nutritionists collected dietary data using a valid and reliable semi-quantitative food frequency questionnaire (FFQ). They questioned usual dietary intakes based on standard portion sizes during the last year through face-to-face personal interviews<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. The consumption frequency of each food item was changed to daily intakes (g/day) using household measures. Due to the uncompleted Iranian food composition table (FCT), the United States Department of Agriculture (USDA) FCT was used to break down the nutrient composition of food items (e.g., bread, legume, nuts, white or red meat) not included in the Iranian FCT.</p><p id="Par24">We used the values of acrylamide content reported in the analysis of 30 food items considering cooking methods and food preparation. The acrylamide content of traditional and industrial breads, bakery products (cakes and biscuits), confectionary products (pastries and chocolates), snacks (potato-based and corn-based), coffee powder, roasted nuts (almonds, pistachios, hazelnuts, peanuts and edible seeds), and fast foods (Pizza, hamburger and sausage) was evaluated. The acrylamide concentration of food was estimated using dispersive liquid&#8211;liquid micro-extraction system coupled with gas-chromatography mass spectrometry<sup><xref ref-type="bibr" rid="CR36">36</xref>&#8211;<xref ref-type="bibr" rid="CR38">38</xref></sup>. The nutrients and acrylamide content of food items were computed cumulatively across follow up surveys from the baseline survey until the point of the last follow-up visit or the time that diabetes diagnosed.</p></sec><sec id="Sec8"><title>Physical activity measurements</title><p id="Par25">An interviewer questioned physical activity levels using Persian-translated modifiable activity questionnaire (MAQ). Previous study reported high reliability and moderate validity of this questionnaire<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Time and frequency of different intensity activities were collected as stated by routine activities of daily life over the past year. These data were changed into metabolic equivalent/minutes/week (MET/min/week)<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>.</p></sec><sec id="Sec9"><title>Blood pressure and anthropometric measurements</title><p id="Par26">Skilled staff measured bodyweight using a digital scale (Seca 707) with a precision of 100&#160;g. Subjects had minimum clothes and were barefoot. Height was measured by a tape measure with an accuracy of 0.5&#160;cm in the standing position without shoes and straightened shoulders. Trained staff measured the waist circumference (WC) in the umbilical region after a normal exhalation without pressure on the body surface in the standing position and with the most miniature clothing to the nearest 0.1&#160;cm.</p><p id="Par27">Qualified physicians evaluated systolic and diastolic blood pressure (SBP, DBP) using a standard mercury sphygmomanometer. They asked participants to rest for 15&#160;min, and then the physician measured blood pressure in the sitting position while setting the cuff on the right arm. They repeated this operation twice with an interval of 30&#160;s. We took the average of two measures in the analysis.</p></sec><sec id="Sec10"><title>Biochemical analysis</title><p id="Par28">Blood samples were collected between 7:00 to 9:00&#160;a.m, after 12&#8211;14&#160;h of overnight fasting. The samples were centrifuged 30 to 45&#160;min after collection. The technician analyzed blood samples using Selectra 2 auto-analyzer at the TLGS research laboratory on the day of blood collection. They quantified FBG concentration using enzymatic colorimetric method and glucose oxidase technique (Vital Scientific, Spankeren, the Netherlands). In follow-up times, they perform the standard 2-h post-challenge blood glucose test using oral administration of 82.5&#160;g glucose monohydrate solution (equivalent to 75&#160;g anhydrous glucose) for all individuals who were not on glucose-lowering drugs.</p><p id="Par29">High-density lipoprotein cholesterol (HDL-C) concentration was evaluated after precipitation of the apolipoprotein B-containing lipoproteins with phosphotungstic acid. Triglyceride (TG) level was assessed by enzymatic colorimetric tests using glycerol phosphate oxidase (Pars Azmoon Inc., Tehran, Iran). For glucose, inter-and intra-assay coefficients of variations were both 2.2%. For TG, inter-and intra-assay coefficients of variations were 1.6% and 0.6%, respectively<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>.</p></sec><sec id="Sec11"><title>Outcome definition</title><p id="Par30">Incidence of T2D was determined as FBG concentrations &#8805;&#8201;126&#160;mg/dl or 2-h plasma glucose concentrations &#8805;&#8201;200&#160;mg/dl or self-reported taking glucose-lowering drugs (oral diabetes medication or insulin injections)<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p></sec><sec id="Sec12"><title>Statistical analysis</title><p id="Par31">We performed statistical analyses using the Statistical Package for Social Sciences (version 21.0; SPSS). A two-sided P value&#8201;&lt;&#8201;0.05 was considered statistically significant. We categorized data into quartiles of acrylamide intake. Chi-square test for categorical variables and one-way ANOVA for continuous variables were used to compare the mean and frequency of participants' baseline characteristics across quartiles of acrylamide intake. P for trend across acrylamide intake categories was performed by assigning continuous variables in a linear regression model. The normality of variables was checked by Kolmogorov&#8211;Smirnov test. Percentage of acrylamide from different food groups across quartiles of total acrylamide intake was computed. Multivariable Cox proportional hazard regression analyses were performed to estimate the hazards ratio (HR) and 95% confidence interval (CI) of incident T2D. The first quartile was assumed as the reference. The median of each quartile was utilized as a continuous variable to estimate the P-value of trends across quartiles of acrylamide intake in the Cox proportional hazard regression models. The confounders were selected based on literature; also, we apply each confounder in the univariable Cox regression model; a two-tailed P-value &lt;&#8201;0.20 was practiced for specifying admission in the model.</p><p id="Par32">Time to event was defined as the time between baseline and the event date (for event cases) or the last follow-up (for censored participants), whichever occurred first. The event date was defined as the mid-time between the follow-up visit date at which T2D was detected for the first time and the most recent follow-up visit before the diagnosis. Study participants were censored due to death, loss to follow-up, or non-occurrence of T2D before the end of follow-up. The Cox regression models were adjusted for several potential confounders. The analyses were performed with sex and age adjustment (model 1). Model 2 was adjusted for education levels (&gt;&#8201;14 and &#8804;&#8201;14&#160;years), smoking (non-exposed, passive smoker, and active smoker), BMI (continuous), physical activity (continuous), family history of type 2 diabetes (yes, no), energy intake (continuous), TG/HDL ratio, plus model 1. Also multivariable Cox proportional hazard regression analyses were performed to estimate the hazards ratio (HR) and 95% confidence interval (CI) of incident T2D in subgroups of sex, smoking and BMI. The proportional hazards assumption was verified using the Schoenfeld residuals test and plot of log [&#8722;&#8201;log (survival)] versus log (time) to see if they are parallel.</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>F.H.-E., N.B., and S.V.-K. collected the data and wrote the first draft of the manuscript with contributions of G.K. and A.N.; P.M. and F.A. also supervised the study. All authors reviewed and approved the final draft of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences (Tehran, Iran) under Grant number 29965.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par33">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rifai</surname><given-names>L</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>FA</given-names></name></person-group><article-title>A review on acrylamide in food: Occurrence, toxicity, and mitigation strategies</article-title><source>Int. J. Toxicol.</source><year>2020</year><volume>39</volume><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1177/1091581820902405</pub-id><pub-id pub-id-type="pmid">32013673</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mottram</surname><given-names>DS</given-names></name><name name-style="western"><surname>Wedzicha</surname><given-names>BL</given-names></name><name name-style="western"><surname>Dodson</surname><given-names>AT</given-names></name></person-group><article-title>Acrylamide is formed in the Maillard reaction</article-title><source>Nature</source><year>2002</year><volume>419</volume><fpage>448</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1038/419448a</pub-id><pub-id pub-id-type="pmid">12368844</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bu&#353;ov&#225;</surname><given-names>M</given-names></name><etal/></person-group><article-title>Risk of exposure to acrylamide</article-title><source>Cent. Eur. J. Public Health</source><year>2020</year><volume>28 Suppl</volume><fpage>S43</fpage><lpage>S46</lpage><pub-id pub-id-type="doi">10.21101/cejph.a6177</pub-id><pub-id pub-id-type="pmid">33069180</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pennisi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Neurotoxicity of acrylamide in exposed workers</article-title><source>Int. J. Environ. Res. Public Health</source><year>2013</year><volume>10</volume><fpage>3843</fpage><lpage>3854</lpage><pub-id pub-id-type="doi">10.3390/ijerph10093843</pub-id><pub-id pub-id-type="pmid">23985770</pub-id><pub-id pub-id-type="pmcid">PMC3799507</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagmar</surname><given-names>L</given-names></name><etal/></person-group><article-title>Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose</article-title><source>Scand. J. Work Environ. Health</source><year>2001</year><volume>27</volume><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.5271/sjweh.608</pub-id><pub-id pub-id-type="pmid">11560335</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shipp</surname><given-names>A</given-names></name><etal/></person-group><article-title>Acrylamide: Review of toxicity data and dose&#8211;response analyses for cancer and noncancer effects</article-title><source>Crit. Rev. Toxicol.</source><year>2006</year><volume>36</volume><fpage>481</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1080/10408440600851377</pub-id><pub-id pub-id-type="pmid">16973444</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friedman</surname><given-names>MA</given-names></name><name name-style="western"><surname>Dulak</surname><given-names>LH</given-names></name><name name-style="western"><surname>Stedham</surname><given-names>MA</given-names></name></person-group><article-title>A lifetime oncogenicity study in rats with acrylamide</article-title><source>Fundam. Appl. Toxicol.</source><year>1995</year><volume>27</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1006/faat.1995.1112</pub-id><pub-id pub-id-type="pmid">7589934</pub-id><pub-id pub-id-type="pmcid">PMC7528933</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Virk-Baker</surname><given-names>MK</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>TR</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>S</given-names></name><name name-style="western"><surname>Groopman</surname><given-names>J</given-names></name></person-group><article-title>Dietary acrylamide and human cancer: A systematic review of literature</article-title><source>Nutr. Cancer</source><year>2014</year><volume>66</volume><fpage>774</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1080/01635581.2014.916323</pub-id><pub-id pub-id-type="pmid">24875401</pub-id><pub-id pub-id-type="pmcid">PMC4164905</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pelucchi</surname><given-names>C</given-names></name><name name-style="western"><surname>Bosetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Galeone</surname><given-names>C</given-names></name><name name-style="western"><surname>La Vecchia</surname><given-names>C</given-names></name></person-group><article-title>Dietary acrylamide and cancer risk: An updated meta-analysis</article-title><source>Int. J. Cancer</source><year>2015</year><volume>136</volume><fpage>2912</fpage><lpage>2922</lpage><pub-id pub-id-type="doi">10.1002/ijc.29339</pub-id><pub-id pub-id-type="pmid">25403648</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">International Agency for Research on Cancer. Some industrial chemicals. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (1994).</mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mori</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Mechanism of reactive oxygen species generation and oxidative DNA damage induced by acrylohydroxamic acid, a putative metabolite of acrylamide</article-title><source>Mutat. Res. Genet. Toxicol. Environ. Mutagen.</source><year>2022</year><volume>873</volume><fpage>503420</fpage><pub-id pub-id-type="doi">10.1016/j.mrgentox.2021.503420</pub-id><pub-id pub-id-type="pmid">35094805</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yousef</surname><given-names>MI</given-names></name><name name-style="western"><surname>El-Demerdash</surname><given-names>FM</given-names></name></person-group><article-title>Acrylamide-induced oxidative stress and biochemical perturbations in rats</article-title><source>Toxicology</source><year>2006</year><volume>219</volume><fpage>133</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2005.11.008</pub-id><pub-id pub-id-type="pmid">16343728</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogurtsova</surname><given-names>K</given-names></name><etal/></person-group><article-title>IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040</article-title><source>Diabetes Res. Clin. Pract.</source><year>2017</year><volume>128</volume><fpage>40</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2017.03.024</pub-id><pub-id pub-id-type="pmid">28437734</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banday</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Sameer</surname><given-names>AS</given-names></name><name name-style="western"><surname>Nissar</surname><given-names>S</given-names></name></person-group><article-title>Pathophysiology of diabetes: An overview</article-title><source>Avicenna J. Med.</source><year>2020</year><volume>10</volume><fpage>174</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.4103/ajm.ajm_53_20</pub-id><pub-id pub-id-type="pmid">33437689</pub-id><pub-id pub-id-type="pmcid">PMC7791288</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dos Santos</surname><given-names>JM</given-names></name><name name-style="western"><surname>Tewari</surname><given-names>S</given-names></name></person-group><article-title>The role of oxidative stress in the development of diabetes mellitus and its complications</article-title><source>J. Diabetes Res.</source><year>2019</year><volume>2019</volume><fpage>4189813</fpage><pub-id pub-id-type="doi">10.1155/2019/4189813</pub-id><pub-id pub-id-type="pmid">31192263</pub-id><pub-id pub-id-type="pmcid">PMC6525877</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Acrylamide exposure and oxidative DNA damage, lipid peroxidation, and fasting plasma glucose alteration: Association and mediation analyses in Chinese urban adults</article-title><source>Diabetes Care</source><year>2020</year><volume>43</volume><fpage>1479</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.2337/dc19-2603</pub-id><pub-id pub-id-type="pmid">32345652</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Association among acrylamide, blood insulin, and insulin resistance in adults</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><fpage>2206</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.2337/dc09-0309</pub-id><pub-id pub-id-type="pmid">19729525</pub-id><pub-id pub-id-type="pmcid">PMC2782978</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Timmermann</surname><given-names>CAG</given-names></name><etal/></person-group><article-title>A review of dietary intake of acrylamide in humans</article-title><source>Toxics</source><year>2021</year><volume>9</volume><fpage>155</fpage><pub-id pub-id-type="doi">10.3390/toxics9070155</pub-id><pub-id pub-id-type="pmid">34209352</pub-id><pub-id pub-id-type="pmcid">PMC8309717</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">EFS Authority. Scientific opinion on acrylamide in food. <italic toggle="yes">EFSA J</italic>. <bold>13</bold> (2015)</mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirmiran</surname><given-names>P</given-names></name><etal/></person-group><article-title>Does dietary intake by Tehranian adults align with the 2005 dietary guidelines for Americans? Observations from the Tehran lipid and glucose study</article-title><source>J. Health Popul. Nutr.</source><year>2011</year><volume>29</volume><fpage>39</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.3329/jhpn.v29i1.7564</pub-id><pub-id pub-id-type="pmid">21528789</pub-id><pub-id pub-id-type="pmcid">PMC3075058</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarion</surname><given-names>C</given-names></name><name name-style="western"><surname>Codin&#259;</surname><given-names>GG</given-names></name></person-group><article-title>Acrylamide in bakery products: A review on health risks, legal regulations and strategies to reduce its formation</article-title><source>Int. J. Environ. Res. Public Health</source><year>2021</year><volume>18</volume><fpage>4332</fpage><pub-id pub-id-type="doi">10.3390/ijerph18084332</pub-id><pub-id pub-id-type="pmid">33921874</pub-id><pub-id pub-id-type="pmcid">PMC8073677</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Associations of hemoglobin biomarker levels of acrylamide and all-cause and cardiovascular disease mortality among U.S. adults: National Health and Nutrition Examination Survey 2003&#8211;2006</article-title><source>Environ. Pollut.</source><year>2018</year><volume>238</volume><fpage>852</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1016/j.envpol.2018.03.109</pub-id><pub-id pub-id-type="pmid">29627755</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagata</surname><given-names>C</given-names></name><etal/></person-group><article-title>Associations of acrylamide intake with urinary sex hormone levels among preschool-age Japanese children</article-title><source>Am. J. Epidemiol.</source><year>2018</year><volume>187</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">29309517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwx197</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheang</surname><given-names>I</given-names></name><etal/></person-group><article-title>Association of acrylamide hemoglobin biomarkers with serum lipid levels in general US population: NHANES 2013&#8211;2016</article-title><source>Ecotoxicol. Environ. Saf.</source><year>2021</year><volume>214</volume><fpage>112111</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2021.112111</pub-id><pub-id pub-id-type="pmid">33690009</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markovi&#263;Filipovi&#263;</surname><given-names>J</given-names></name><name name-style="western"><surname>Karan</surname><given-names>J</given-names></name></person-group><article-title>Acrylamide and potential risk of diabetes mellitus: Effects on human population, glucose metabolism and beta-cell toxicity</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><fpage>6112</fpage><pub-id pub-id-type="doi">10.3390/ijms23116112</pub-id><pub-id pub-id-type="pmid">35682790</pub-id><pub-id pub-id-type="pmcid">PMC9181725</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>G</given-names></name><name name-style="western"><surname>Liao</surname><given-names>S</given-names></name><name name-style="western"><surname>Gong</surname><given-names>D</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>H</given-names></name></person-group><article-title>Association of acrylamide and glycidamide haemoglobin adduct levels with diabetes mellitus in the general population</article-title><source>Environ. Pollut.</source><year>2021</year><volume>277</volume><fpage>116816</fpage><pub-id pub-id-type="doi">10.1016/j.envpol.2021.116816</pub-id><pub-id pub-id-type="pmid">33667748</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Exposure to acrylamide and the risk of cardiovascular diseases in the National Health and Nutrition Examination Survey 2003&#8211;2006</article-title><source>Environ. Int.</source><year>2018</year><volume>117</volume><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2018.04.047</pub-id><pub-id pub-id-type="pmid">29753146</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Effect of acrylamide on glucose homeostasis in female rats and its mechanisms</article-title><source>Food Chem. Toxicol.</source><year>2020</year><volume>135</volume><fpage>110894</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110894</pub-id><pub-id pub-id-type="pmid">31644924</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>HW</given-names></name><name name-style="western"><surname>Pyo</surname><given-names>S</given-names></name></person-group><article-title>Acrylamide induces adipocyte differentiation and obesity in mice</article-title><source>Chem. Biol. Interact.</source><year>2019</year><volume>298</volume><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2018.10.021</pub-id><pub-id pub-id-type="pmid">30409764</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosseini-Esfahani</surname><given-names>F</given-names></name><etal/></person-group><article-title>Does the diet of Tehranian adults ensure compliance with nutritional targets? Observations from the Tehran Lipid and Glucose Study</article-title><source>Public Health Nutr.</source><year>2011</year><volume>14</volume><fpage>1539</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1017/S1368980011000711</pub-id><pub-id pub-id-type="pmid">21557877</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosseini-Esfahani</surname><given-names>F</given-names></name><etal/></person-group><article-title>Metabolic syndrome: Findings from 20 years of the Tehran lipid and glucose study</article-title><source>Int. J. Endocrinol. Metab.</source><year>2018</year><volume>16</volume><fpage>e84771</fpage><pub-id pub-id-type="doi">10.5812/ijem.84791</pub-id><pub-id pub-id-type="pmid">30584438</pub-id><pub-id pub-id-type="pmcid">PMC6289295</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>Issues in analysis and presentation of dietary data</article-title><source>Nutritional Epidemiology</source><year>1998</year><edition>2</edition><publisher-name>Oxford University Press</publisher-name><fpage>321</fpage><lpage>346</lpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>Classification and diagnosis of diabetes: Standards of medical care in diabetes&#8212;2019</article-title><source>Diabetes Care</source><year>2019</year><volume>42</volume><fpage>S13</fpage><lpage>S28</lpage><pub-id pub-id-type="doi">10.2337/dc19-S002</pub-id><pub-id pub-id-type="pmid">30559228</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esfahani</surname><given-names>FH</given-names></name><name name-style="western"><surname>Asghari</surname><given-names>G</given-names></name><name name-style="western"><surname>Mirmiran</surname><given-names>P</given-names></name><name name-style="western"><surname>Azizi</surname><given-names>F</given-names></name></person-group><article-title>Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study</article-title><source>J. Epidemiol.</source><year>2010</year><volume>20</volume><fpage>150</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.2188/jea.JE20090083</pub-id><pub-id pub-id-type="pmid">20154450</pub-id><pub-id pub-id-type="pmcid">PMC3900814</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirmiran</surname><given-names>P</given-names></name><etal/></person-group><article-title>Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study</article-title><source>Public Health Nutr.</source><year>2010</year><volume>13</volume><fpage>654</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1017/S1368980009991698</pub-id><pub-id pub-id-type="pmid">19807937</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nematollahi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Investigation and determination of acrylamide in the main group of cereal products using advanced microextraction method coupled with gas chromatography-mass spectrometry</article-title><source>J. Cereal Sci.</source><year>2019</year><volume>87</volume><fpage>157</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.jcs.2019.03.019</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nematollahi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Acrylamide content of collected food products from Tehran's market: A risk assessment study</article-title><source>Environ. Sci. Pollut. Res. Int.</source><year>2020</year><volume>27</volume><fpage>30558</fpage><lpage>30570</lpage><pub-id pub-id-type="doi">10.1007/s11356-020-09323-w</pub-id><pub-id pub-id-type="pmid">32468359</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nematollahi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Investigation and determination of acrylamide in 24 types of roasted nuts and seeds using microextraction method coupled with gas chromatography&#8211;mass spectrometry: Central composite design</article-title><source>J. Food Meas. Charact.</source><year>2020</year><volume>14</volume><fpage>1249</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1007/s11694-020-00373-9</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Momenan</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Reliability and validity of the Modifiable Activity Questionnaire (MAQ) in an Iranian urban adult population</article-title><source>Arch. Iran. Med.</source><year>2012</year><volume>15</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">22519376</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ainsworth</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Compendium of physical activities: An update of activity codes and MET intensities</article-title><source>Med. Sci. Sports Exerc.</source><year>2000</year><volume>32</volume><fpage>S498</fpage><lpage>S504</lpage><pub-id pub-id-type="doi">10.1097/00005768-200009001-00009</pub-id><pub-id pub-id-type="pmid">10993420</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azizi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II</article-title><source>Trials</source><year>2009</year><volume>10</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/1745-6215-10-5</pub-id><pub-id pub-id-type="pmid">19166627</pub-id><pub-id pub-id-type="pmcid">PMC2656492</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>